These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
127 related items for PubMed ID: 954014
1. The nitrosoureas--thoughts for the future. Carter SK, Wasserman TH. Cancer Treat Rep; 1976 Jun; 60(6):807-11. PubMed ID: 954014 [No Abstract] [Full Text] [Related]
2. Therapy for gastrointestinal cancer with the nitrosoureas alone and in drug combination. Moertel CG, Schutt AJ, Reitemeier RJ, Hahn RG. Cancer Treat Rep; 1976 Jun; 60(6):729-32. PubMed ID: 954012 [No Abstract] [Full Text] [Related]
3. Nitrosoureas: useful agents for the treatment of advanced gastrointestinal cancer. Douglass HO, Lavin PT, Moertel CG. Cancer Treat Rep; 1976 Jun; 60(6):769-80. PubMed ID: 782699 [Abstract] [Full Text] [Related]
4. Randomized prospective trial comparing 5-fluorouracil (NSC-19893) to 5-fluorouracil and methyl-CCNU (NSC-95441) in advanced gastrointestinal cancer. Baker LH, Vaitkevicius VK, Gehan E. Cancer Treat Rep; 1976 Jun; 60(6):733-7. PubMed ID: 954013 [Abstract] [Full Text] [Related]
5. Therapy of advanced gastrointestinal cancer with the nitrosoureas. Moertel CG. Cancer Chemother Rep 3; 1973 May; 4(3):27-34. PubMed ID: 4748872 [No Abstract] [Full Text] [Related]
6. A controlled study of 5-fluorouracil versus 5-fluorouracil and methyl-CCNU in advanced gastrointestinal adenocarcinoma. Abdallah AM, Soukop M, Bell G, Calman KC. Clin Oncol; 1977 Sep; 3(3):247-57. PubMed ID: 334430 [No Abstract] [Full Text] [Related]
7. [Treatment of advanced digestive cancer with fluorouracil and methyl-CCNU]. Fleischer I, Wainstein R, Jovtis S, Colombato LO. Acta Gastroenterol Latinoam; 1978 Sep; 8(3):191-3. PubMed ID: 747086 [Abstract] [Full Text] [Related]
13. Some drugs for treating neoplasms. Healy JB. Ir Med J; 1978 May 26; 71(8):264-7. PubMed ID: 77265 [No Abstract] [Full Text] [Related]
14. Methyl-CCNU (NSCU-95441) versus methyl-CCNU plus cyclophosphamide (NSC-26271) in advanced gastrointestinal cancer. Rossi A, Riva A, Bonadonna G. Cancer Chemother Rep; 1975 May 26; 59(6):1161-2. PubMed ID: 769958 [No Abstract] [Full Text] [Related]
15. Effects of patient selection on results of phase II chemotherapy trials in gastrointestinal cancer. Moertel CG, Schutt AJ, Hahn RG, Reitemeier RJ. Cancer Chemother Rep; 1974 May 26; 58(2):257-9. PubMed ID: 4830499 [No Abstract] [Full Text] [Related]
16. 5-Fluorouracil (5-FU), methyl-CCNU, and vincristine in the treatment of advanced colorectal cancer: phase II study utilizing weekly 5-FU. Macdonald JS, Kisner DF, Smythe T, Woolley PV, Smith L, Schein PS. Cancer Treat Rep; 1976 Nov 26; 60(11):1597-600. PubMed ID: 1021233 [Abstract] [Full Text] [Related]
17. Nitrosoureas in the management of disseminated malignant melanoma. Ahmann DL. Cancer Treat Rep; 1976 Jun 26; 60(6):747-51. PubMed ID: 782696 [Abstract] [Full Text] [Related]
20. Phase I trial of combination methotrexate and methyl-CCNU in patients with advanced neoplastic diseases. Lehane DE, Lane M, Tranum B, Costanzi J, Padilla F. Cancer Treat Rep; 1977 Aug 26; 61(5):889-91. PubMed ID: 329982 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]